By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Endocrine Society 

4350 East West Highway, Suite 500

Bethesda  Maryland  20814-4410  U.S.A.
Phone: 301-941-0200 Fax: 301-941-0259


Company News
Eisai Inc. (ESALF.PK) Release: Survey Presented At The Joint Annual Meeting Of The International Congress Of Endocrinology And The Endocrine Society (ICE/ENDO 2014) Shows Most Of Those Affected By Obesity Are Not Taking Steps To Lose Weight 6/23/2014 6:13:36 AM
NPS Pharmaceuticals, Inc. (NPSP) to Present Data from Natpara™ REPLACE Study and PARADOX Study at ENDO 2013, the Endocrine Society’s 95th Annual Meeting 6/5/2013 7:02:23 AM
The Ezra Company Negotiates Strong Deal for the Endocrine Society in Its Purchase of 34,000 Square Feet at 2055 L St. NW in Washington, D.C. 5/28/2013 11:12:07 AM
TherapeuticsMD, Inc. Announces Plans in Hormone Therapy That Concur With the Recent Joint Statement from NAMS, ASRM and The Endocrine Society 7/10/2012 10:35:15 AM
Radius Announces Upcoming Scientific Presentations at ENDO 2012, the Endocrine Society's 94th Annual Meeting 6/22/2012 10:55:32 AM
Experts Find Continuous Glucose Monitoring Beneficial in Maintaining Target Blood Glucose Levels, Endocrine Society Reveals 10/12/2011 8:00:31 AM
Ligand Pharmaceuticals Inc. (LGND) Presents Multi-Dose Phase I Data on Lead SARM Molecule LGD-4033 at the Endocrine Society Annual Meeting 6/6/2011 11:46:37 AM
Versartis, Inc. Long-Term Preclinical Safety Data for VRS-317 Presented at Endocrine Society 2011 6/6/2011 9:28:27 AM
Corcept Therapeutics Inc. (CORT) Announces Conference Call to Discuss Detailed Findings From Corlux Phase 3 Trial in Cushing's Syndrome at the Endocrine Society's Annual Meeting 6/1/2011 6:33:40 AM
Corcept Therapeutics Inc. (CORT) to Present Detailed Findings From CORLUX Phase 3 Trial in Cushing's Syndrome at the Endocrine Society's Annual Meeting, June 4-7 5/19/2011 9:03:23 AM